Engineered cord blood megakaryocytes evade killing by allogeneic T-cells for refractory thrombocytopenia Article

Kumar, Bijender, Afshar-Kharghan, Vahid, Mendt, Mayela et al. (2022). Engineered cord blood megakaryocytes evade killing by allogeneic T-cells for refractory thrombocytopenia . FRONTIERS IN IMMUNOLOGY, 13 10.3389/fimmu.2022.1018047

Open Access

cited authors

  • Kumar, Bijender; Afshar-Kharghan, Vahid; Mendt, Mayela; Sackstein, Robert; Tanner, Mark RR; Popat, Uday; Ramdial, Jeremy; Daher, May; Jimenez, Juan; Basar, Rafet; Garcia, Luciana Melo; Shanley, Mayra; Kaplan, Mecit; Wan, Xinhai; Nandivada, Vandana; Silva, Francia Reyes; Woods, Vernikka; Gilbert, April; Gonzalez-Delgado, Ricardo; Acharya, Sunil; Lin, Paul; Rafei, Hind; Banerjee, Pinaki Prosad; Shpall, Elizabeth J

sustainable development goals

publication date

  • September 20, 2022

published in

keywords

  • EMBRYONIC STEM-CELLS
  • ENDOMITOSIS
  • GENERATION
  • HLA-E
  • IN-VITRO
  • Immunology
  • Life Sciences & Biomedicine
  • NATURAL-KILLER-CELLS
  • PLATELET TRANSFUSION
  • PROPLATELET FORMATION
  • Science & Technology
  • THROMBOPOIESIS
  • VIVO
  • beta2 microglobin
  • cord blood
  • megakaryocyte
  • platelet
  • rho-associated coiled coil-containing protein kinase
  • thrombocytopaenia

Digital Object Identifier (DOI)

publisher

  • FRONTIERS MEDIA SA

volume

  • 13